This independent overview frames Ozempic versus Wegovy as a set of decision layers, from active ingredient and indication to evidence, safety, cost, and genetics, showing why the shared semaglutide molecule makes labeled indication and genetic context the inputs that matter most in the comparison.

This independent overview maps the incretin category that surrounds Ozempic and Mounjaro, covering GLP-1-selective, dual, and investigational agents, FDA approval timelines, the major trial programs, class-wide safety, the list-price spread, and the shared genetics behind every compound in the family.

Mounjaro and Zepbound are one tirzepatide molecule sold under two Eli Lilly names. This explainer situates them within the wider incretin class, walks through the field's approvals, trials, and class-wide safety, explains April 2026 list pricing, and describes the pathway biology that no brand name on the pen ever alters.

This field-guide comparison places Ozempic and Mounjaro inside the wider incretin category, mapping FDA approvals across the class, decoding the trial acronyms, framing class-wide safety, explaining the April 2026 list-price range, and pointing to the genetic baseline that sits beneath every branded option a clinician might reach for.

Eden vs GALA GLP-1 vs PlexusDx (verified July 2026): Eden's $99 advertised price runs $198/mo all-in with its required membership; GALA is the lowest annual-commitment price; PlexusDx pairs six month-to-month compounded protocols with the Precision Peptide Genetic Test.

Compare the 2026 best Foundayo (orforglipron) providers — Ro, Found, Form Health, Sesame Care, Weight Watchers Med+, and LillyDirect — and see where the PlexusDx Weight Management Protocols fit as a cash-pay, genetics-informed alternative when insurance excludes weight-loss drugs.

Piper (rebranding to Polly April 29, 2026) vs Gala GLP-1 vs PlexusDx: verified April 2026 pricing, pharmacy transparency, cancellation rules, and where a genetic baseline changes the dosing conversation.

GLP-3 retatrutide explained: triple-agonist mechanism, Phase 3 TRIUMPH data, dysesthesia signal, FDA timeline, and how PlexusDx’s currently-available compounded semaglutide and tirzepatide protocols compare to the pipeline asset.

Mounjaro is FDA-approved tirzepatide for type 2 diabetes; Zepbound is the weight-loss-indicated brand. Compare branded Mounjaro online vs cash-pay compounded tirzepatide and where PlexusDx Tirzepatide Injection ($289/mo) fits.

Eight month-to-month GLP-1 providers compared against PlexusDx Weight Management Protocols on real annual cost, separate membership fees, intro-price cliffs, and genetic baseline. PlexusDx Microdose at $129/mo flat, Semaglutide Injection $189, Tirzepatide Injection $289, GLP-Squared $289 — all cash-pay, no membership.

MEDVi shipping time is a published 5–7 business days — physician review, compounding-pharmacy processing, and carrier transit. See how that timeline compares to PlexusDx Weight Management Protocols, which ship to all 50 states with shipping included in the all-inclusive monthly price (from $129/mo) and no membership fee.

TrimRx vs Henry Meds vs PlexusDx compared on real annual cost, pricing labels, reviews, and genetics. TrimRx advertises $199/mo semaglutide but its checkout billed $299/mo in July 2026; Henry Meds lists $297/mo; PlexusDx runs from $129/mo with an optional genetic test ($298, or $99 for program members).

The best tirzepatide online in 2026 depends on insurance status, format, and whether you want a genetic baseline guiding titration. Compare MEDVi, YUCCA Health, Willow, Eden, and TrimRx against PlexusDx Tirzepatide Injection ($289/mo) and Tirzepatide Oral ($349/mo), with the optional Precision Peptide Genetic Test for pathway-level context.

TrimRx vs Ro vs PlexusDx in 2026: real annual cost math, compounded vs FDA-approved branded medication, oral pill options, safety oversight, and PlexusDx's optional genetic-baseline test. Includes a four-question decision frame and pricing across PlexusDx Microdose GLP-1, Semaglutide Injection, Tirzepatide Injection, and GLP-Squared.

SkinnyRx vs MEDVi vs PlexusDx compared on cost, formats, oversight, FDA warning letters, and genetic personalization — with PlexusDx Microdose at $129/mo flat as the cheapest cash-pay tier and the Precision Peptide Genetic Test as the only genetic baseline in the three-way comparison.

SHED vs Ro vs PlexusDx for cash-pay GLP-1 weight loss in 2026 — compounded vs FDA-approved branded, real annual cost math, insurance posture, format flexibility, and why genetics inform PlexusDx dose decisions before week one.

Rybelsus (oral semaglutide) is FDA-approved for type 2 diabetes only — not for weight loss. See the real PIONEER weight numbers, the ~$998/month cash price, why insurance rarely covers off-label use, and how PlexusDx Semaglutide Oral ($289/mo+) and the Microdose GLP-1 Protocol ($129/mo) compare on cost and dose flexibility.

Retatrutide (Lilly's investigational triple agonist) and orforglipron (Lilly's oral non-peptide GLP-1) are the two big pipeline stories in 2026 — but neither is FDA-approved yet. Here's the realistic timeline, the Phase 3 data, the announced and unknown pricing, and how PlexusDx's currently-available compounded semaglutide and tirzepatide protocols ($129/mo to $349/mo) compare for someone who needs an option today rather than in 2028.

Oral semaglutide vs injectable semaglutide in 2026: Rybelsus, the new Wegovy pill, Ozempic, and Wegovy injection compared on dose, bioavailability, effectiveness, and cost — plus where PlexusDx Semaglutide Oral ($289/mo+), Semaglutide Injection ($189/mo), and Microdose GLP-1 Protocol ($129/mo flat) fit as cash-pay alternatives covering both pill and shot formats.

MEDVi vs TrimRx vs PlexusDx in 2026: real cash-pay GLP-1 pricing, compounded vs branded, multi-month upfront vs month-to-month, and where genetic testing changes the dose conversation before week one.

MEDVi vs Ro vs PlexusDx for cash-pay GLP-1 weight loss: real annualized cost math, compounded vs FDA-approved branded, safety considerations, and where genetic baselining changes the dose decision before week one.

MEDVi, Remedy Meds, and PlexusDx all dispense compounded semaglutide and tirzepatide — but the annualized cost, billing cadence, and clinical-oversight model differ in ways the landing pages don't show. This guide walks the real numbers, the September 2025 FDA warning-letter context, and where PlexusDx Weight Management Protocols ($129/mo to $349/mo) plus the Precision Peptide Genetic Test fit relative to both.

MEDVi vs Lilly Direct vs PlexusDx in 2026: all-inclusive compounded telehealth, FDA-approved Zepbound at self-pay vial pricing, and a genetics-anchored compounded protocol. Real 12-month math, the 45-day refill trap, and where each fits.

MEDVi vs Hims vs PlexusDx in 2026: MEDVi at $299/mo ongoing (after a $159 first month) with no contract, Hims at $199/mo gated behind a $1,194 six-month prepayment, and PlexusDx Weight Management Protocols from $129/mo with no upfront commitment and an optional Precision Peptide Genetic Test for genetic-guided GLP-1 dosing.

MEDVi vs Hers vs PlexusDx in 2026: real annual cost math, compounded vs FDA-approved branded medication source, tirzepatide availability across all three, cancellation and refund policy differences, and where the Precision Peptide Genetic Test fits when GLP-1 response varies by GLP1R, GIPR, FTO, MC4R, and TCF7L2 variants.

MEDVi vs Gala GLP-1 vs PlexusDx compared on verified 2026 pricing, compounded vs FDA-approved status, cancellation rules, and where a genetic baseline changes the dose decision before week one.

Eden vs Ro vs PlexusDx for cash-pay GLP-1: Eden's $99 advertised semaglutide runs $198/mo all-in with its required membership (verified July 2026); Ro pairs a $149/mo membership with branded medication billed on top; PlexusDx runs $129/mo to $349/mo month to month with an optional genetic baseline.

Compare the best online tirzepatide providers in 2026 — Ro, Eden, Yucca Health, Willow, Sesame — against the PlexusDx Tirzepatide Injection ($289/mo) and Tirzepatide Oral ($349/mo) Protocols, with a genetic baseline option no other provider offers.

How PlexusDx Weight Management Protocols compare to the major cash-pay GLP-1 programs in 2026 — Mochi, Eden, MEDVi, Ro, GoodRx Care Direct, NovoCare, and LillyDirect — on price, medication source, membership fees, and total annualized cost.